Safingol

DB11924InvestigationalSmall molecule

Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Mechanism: Pharmacologically active on Protein kinase C alpha type, Sphingosine kinase 1, and Protein kinase C
Curator reviewed
Formula / weight: C₁₈H₃₉NO₂ · 301.515 g/mol (avg)
Code names: SPC-100270

Resolves to

Compound

Structure

InChIKeyOTKJDMGTUTTYMP-ROUUACIJSA-NSMILESCCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO

Targets

What you can answer from here — as of September 19, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Safingol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.